Stay updated with breaking news from Iontech. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Updated analysis from 34 cases occurring at least seven days following a three-dose regimen showed 73.2% vaccine efficacy among children ages 6 months through 4 years The vaccine efficacy
Pfizer's COVID-19 vaccine was 73% effective in protecting children younger than 5 as...
Moderna is expected to file a similar application soon
In a statement issued on Monday, the two companies said that data support request for Emergency Use Authorization of a 30yg booster dose of an Omicron BA.4/BA.5-adapted bivalent COVID-19 vaccine for individuals 12 years of age and older.
This updated formulation will combine the original vaccine with one that targets Omicron sublineages BA.4 and BA.5, and would be administered as a 30 microgram dose.